Overview

  • Organization TypeService Providers
  • Staff101-250
  • HeadquartersUnited States
  • Founded1981
BIOQUAL was established in 1981, and performs contract research services focused on in vivo models of human diseases including AIDS, influenza, RSV infection, Flavivirus infections including Zika and Dengue, malaria, hepatitis, and cancer. BIOQUAL has laboratories and vivariums under both BSL-2 and BSL-3 containment. In addition, BIOQUAL maintains CDC-approved BSL-3 containment laboratories for studies associated with Select Agents including highly pathogenic avian influenza. BIOQUAL’s laboratories are actively involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. In vitro services are available for evaluation of immunologic, virologic, and molecular parameters. These services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. BIOQUAL, Inc. is fully accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and has a long history of providing state-of-the-art facilities and trained, experienced research scientists, veterinarians and animal care personnel for clients involved in infectious disease investigations, cancer research, and a wide variety of other in vivo and in vitro studies including those requiring Good Laboratory Practice (GLP) documentation and conditions.

Where is Bioqual Inc.
Projects1Location of contracts awarded

Contact Bioqual Inc.

Company Offices
  • United States (headquarters)
  • Rockville
  • 4 Research Court Rockville,

Experience

Contract Awards

Pre-clinical Models of Infectious Diseases

United States Department of Health & Human Services (DHHS), National Institutes of Health (NIH) - United States
18 Jul 2017